{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:48:22Z","timestamp":1761468502080,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.tube.2020.101984","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T21:47:42Z","timestamp":1597182462000},"page":"101984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-8137","authenticated-orcid":false,"given":"Fregenet","family":"Tesfaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Stureg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-7741","authenticated-orcid":false,"given":"John","family":"Walles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-7501","authenticated-orcid":false,"given":"Niclas","family":"Winqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taye Tolera","family":"Balcha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Karlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daba","family":"Mulleta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Erik","family":"Isberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2020.101984_bib1","article-title":"Increased risk of active tuberculosis during pregnancy and postpartum\u00a0: a register-based cohort study in Sweden","author":"Jonsson","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2020.101984_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1164\/rccm.201106-1083OC","article-title":"Risk of tuberculosis in pregnancy A national , primary care \u2013 based cohort and self-controlled case series study","volume":"185","author":"Zenner","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2020.101984_bib3","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.5588\/ijtld.16.0314","article-title":"Risk of tuberculosis during pregnancy in Mongolia , a high incidence setting with low HIV prevalence","volume":"20","author":"Rendell","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.tube.2020.101984_bib4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(10)60518-1","article-title":"Maternal mortality for 181 countries , 1980 \u2013 2008\u00a0: a systematic analysis of progress towards Millennium Development Goal 5","volume":"375","author":"Hogan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2020.101984_bib5","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/infdis\/jis009","article-title":"Prevention , diagnosis , and treatment of tuberculosis in children and Mothers\u00a0: evidence for action for maternal , neonatal , and child health services","volume":"205","author":"Getahun","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2020.101984_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAI.0b013e31821ac9c1","article-title":"Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in soweto , South Africa","volume":"57","author":"Gounder","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tube.2020.101984_bib7","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1086\/657411","article-title":"Latent tuberculosis detection by interferon g release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1 \u2013 infected women and their children","volume":"202","author":"Jonnalagadda","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2020.101984_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092308","article-title":"Pregnancy differentially impacts performance of latent tuberculosis diagnostics in a high-burden setting","volume":"9","author":"Mathad","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2020.101984_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/QAI.0000000000001298","article-title":"Effect of pregnancy on interferon gamma release-assay and tuberculin skin test detection of latent TB infection among HIV-infected women in a high burden setting","volume":"75","author":"LaCourse","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"year":"2015","series-title":"QuantiFERON \u00ae - TB gold plus (QFT \u00ae -plus) ELISA package insert 2\/2015","author":"Qiagen","key":"10.1016\/j.tube.2020.101984_bib10"},{"key":"10.1016\/j.tube.2020.101984_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2020.101984_bib12","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection \u2014 United States , 2010 department of health and human services","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.tube.2020.101984_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6673-7-6","article-title":"Interferon-gamma release assays for the tuberculosis serial testing of health care workers\u00a0: a systematic review","volume":"7","author":"Ringshausen","year":"2012","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.tube.2020.101984_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/thx.2010.143180","article-title":"Interferon-gamma release assays for tuberculosis screening of healthcare workers\u00a0: a systematic review","volume":"67","author":"Zwerling","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.tube.2020.101984_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2020.101984_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals \u2013 a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tube.2020.101984_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JCM.02803-15","article-title":"Interferon gamma release assays for latent Tuberculosis\u00a0: what are the sources of Variability\u00a0?","volume":"54","author":"Banaei","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2020.101984_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2018.06.002","article-title":"Borderline QuantiFERON results and the distinction between specific responses and test variability","volume":"111","author":"Uzorka","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2020.101984_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187313","article-title":"A borderline range for Quantiferon Gold In- Tube results","volume":"12","author":"Jonsson","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2020.101984_bib20","article-title":"Performance of QuantiFERON-TB gold plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting","volume":"13","author":"Walles","year":"2018","journal-title":"PloS One"},{"author":"Bjorkman","key":"10.1016\/j.tube.2020.101984_bib21"},{"key":"10.1016\/j.tube.2020.101984_bib22","first-page":"1","article-title":"National consolidated guidelines for comprehensive HIV prevention, care and treatment","year":"2018","journal-title":"FMOH"},{"key":"10.1016\/j.tube.2020.101984_bib23","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2020.101984_bib24","first-page":"1","article-title":"IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay","volume":"6","author":"Ruhwald","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.tube.2020.101984_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2020.101984_bib26","first-page":"580","article-title":"The responses of multiple cytokines following incubation of whole blood from TB patients , latently infected individuals and controls with the TB antigens","volume":"10","author":"Kim","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tube.2020.101984_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12948-015-0015-y","article-title":"T helper cell mediated-tolerance towards fetal allograft in successful pregnancy","volume":"13","author":"Piccinni","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.tube.2020.101984_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12595","article-title":"The T helper type 17\/regulatory T cell paradigm in pregnancy","volume":"148","author":"Figueiredo","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2020.101984_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/erm.11.97","article-title":"Directions IP-10 release assays in the diagnosis of tuberculosis infection\u00a0: current status and future directions","volume":"12","author":"Ruhwald","year":"2012","journal-title":"Expert Rev Mol Diagn ISSN"},{"key":"10.1016\/j.tube.2020.101984_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinf.2012.03.017","article-title":"IP-10 is an additional marker for tuberculosis ( TB ) detection in HIV-infected persons in a low-TB endemic country","volume":"65","author":"Vanini","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2020.101984_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012577","article-title":"Is IP-10 an accurate marker for detecting M . tuberculosis-specific response in HIV-infected Persons\u00a0?","volume":"5","author":"Goletti","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2020.101984_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146098","article-title":"The use of interferon gamma inducible protein 10 as a potential biomarker in the diagnosis of latent tuberculosis infection in Uganda","volume":"11","author":"Biraro","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2020.101984_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2567.2001.01274.x","article-title":"Changes in gene expression in macrophages infected with Mycobacterium tuberculosis\u00a0: a combined transcriptomic and proteomic approach","volume":"104","author":"Ragno","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2020.101984_bib34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3904\/kjim.2003.18.3.138","article-title":"Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis","volume":"18","author":"Lee","year":"2003","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.tube.2020.101984_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-9-105","article-title":"Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area","volume":"9","author":"Winqvist","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2020.101984_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3201\/eid2403.171633","article-title":"Characteristics associated with negative interferon-\u03b3 release assay results in culture-confirmed tuberculosis patients, Texas, USA","volume":"24","author":"Nguyen","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tube.2020.101984_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0187313","article-title":"A borderline range for Quantiferon Gold In- Tube results","volume":"12","author":"Jonsson","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2020.101984_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2011.05.008","article-title":"Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection","volume":"370","author":"Borgstr\u00f6m","year":"2011","journal-title":"J Immunol Methods"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979220301517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979220301517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:45:09Z","timestamp":1761468309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979220301517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":38,"alternative-id":["S1472979220301517"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2020.101984","relation":{},"ISSN":["1472-9792"],"issn-type":[{"type":"print","value":"1472-9792"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2020.101984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101984"}}